CORRECTION OF MICROBIAL CONTAMINATION PARAMETERS AND LOCAL NONSPECIFIC IMMUNE STATUS IN THE ORAL FLUID OF PATIENTS WITH CHRONIC GENERALIZED PERIODONTITIS, OSTEOPENIA, AND OSTEOPOROSIS USING A THERAPEUTIC AND PROPHYLACTIC COMPLEX
Clinical medicine

CORRECTION OF MICROBIAL CONTAMINATION PARAMETERS AND LOCAL NONSPECIFIC IMMUNE STATUS IN THE ORAL FLUID OF PATIENTS WITH CHRONIC GENERALIZED PERIODONTITIS, OSTEOPENIA, AND OSTEOPOROSIS USING A THERAPEUTIC AND PROPHYLACTIC COMPLEX

Published 2026-09-30

Authors:

Hurtova Y.M.
State Establishment "The Institute of Stomatology and Maxillofacial Surgery of the National Academy of Medical Sciences of Ukraine"
https://orcid.org/0009-0001-7610-782X
Humeniuk V.V.
Danylo Halytsky Lviv National Medical University image/svg+xml
https://orcid.org/0000-0003-2736-3875
Svitlichna O.M.
Odessa National Medical University image/svg+xml
https://orcid.org/0000-0003-2073-176X
Savvova A.O.
Odessa National Medical University image/svg+xml
https://orcid.org/0009-0003-3466-1026
Sapalov S.O.
Zaporizhzhia State Medical and Pharmaceutical University image/svg+xml
https://orcid.org/0000-0002-9536-2367
Levina O.O.
Odessa National Medical University image/svg+xml
https://orcid.org/0009-0000-4079-9177

Abstract:
Changes in oral fluid urease and lysozyme activities were assessed in patients with chronic generalised periodontitis associated with osteopenia and osteoporosis. Thirty-five adults aged 25–55 years were examined: 10 healthy individuals, 12 comparison-group patients receiving standard therapy, and 13 main-group patients receiving an adjunctive therapeutic and prophylactic complex. Assessments were performed before treatment and at 3 and 8 months, 1.5 years, and 2 years. In the main group, urease activity decreased from 0.181±0.010 to 0.055±0.003 μkat/L at 8 months and was 0.070±0.004 μkat/L at 2 years. Lysozyme activity increased from 68±3 to 165±12 U/L at 1.5 years and was 152±11 U/L at 2 years. The comparison group showed no sustained urease reduction and less pronounced lysozyme changes. The findings describe favourable biochemical changes with the complex.
Keywords:
chronic generalised periodontitis osteopenia osteoporosis oral fluid urease lysozyme therapeutic and prophylactic complex
References:
  1. Arroyo E, Oliveira-Alves MG, Chamorro-Petronacci CM, Marichalar-Mendia X, Bravo-López SB, Blanco-Carrión J, et al. Protein-based salivary biomarkers for the diagnosis of periodontal diseases: systematic review and meta-analysis. J Taibah Univ Med Sci. 2023;18(4):737–747. DOI:10.1016/j.jtumed.2022.12.004.
  2. Curtis MA, Diaz PI, Van Dyke TE. The role of the microbiota in periodontal disease. Periodontol 2000. 2020;83(1):14–25. DOI:10.1111/prd.12296.
  3. D’souza LL, Lawande SA, Samuel J, Pinto MJW. Effect of salivary urea, pH and ureolytic microflora on dental calculus formation and its correlation with periodontal status. J Oral Biol Craniofac Res. 2023;13(1):8–12. DOI:10.1016/j.jobcr.2022.10.004.
  4. Ferraboschi P, Ciceri S, Grisenti P. Applications of lysozyme, an innate immune defense factor, as an alternative antibiotic. Antibiotics (Basel). 2021;10(12):1534. DOI:10.3390/antibiotics10121534.
  5. Graves DT, Corrêa JD, Silva TA. The oral microbiota is modified by systemic diseases. J Dent Res. 2019;98(2):148–156. DOI:10.1177/0022034518805739.
  6. Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21(7):426–440. DOI:10.1038/s41577-020-00488-6.
  7. Katsiki P, Nazmi K, Loos BG, Laine ML, Schaap K, Hepdenizli E, et al. Comparing periodontitis biomarkers in saliva, oral rinse and gingival crevicular fluid: a pilot study. J Clin Periodontol. 2021;48(9):1250–1259. DOI:10.1111/jcpe.13479.
  8. Moszura J, Gawlak-Socka S, Pęksa J, Bielecka-Kowalska N, Kłosek S. The role of vitamin D3 in periodontal health: implications for bone metabolism, immune modulation and inflammation control. Nutrients. 2026;18(4):577. DOI:10.3390/nu18040577.
  9. Sanz M, Herrera D, Kebschull M, Chapple I, Jepsen S, Berglundh T, et al. Treatment of stage I–III periodontitis-The EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47 Suppl 22:4–60. DOI:10.1111/jcpe.13290.
  10. Uchida H, Ovitt CE. Novel impacts of saliva with regard to oral health. J Prosthet Dent. 2022;127(3):383–391. DOI:10.1016/j.prosdent.2021.05.009.
  11. Van Dyke TE, Bartold PM, Reynolds EC. The nexus between periodontal inflammation and dysbiosis. Front Immunol. 2020;11:511. DOI:10.3389/fimmu.2020.00511.
  12. Wang N, Qian J, Wang M, Li L, Liao W, Chen R, et al. Periodontitis-associated salivary microbiota exacerbates systemic osteoclastogenesis via gut modulation and tryptophan metabolism suppression in ovariectomized mice. Int J Oral Sci. 2026;18:14. DOI:10.1038/s41368-025-00415-2.
  13. Yarov YuYu, Silenko YuI, Yeroshenko GA, Shevchenko KV, Grygorenko AS. Dynamics of local immunological indicators accompanied by different types of reactivity of the organism. World Med Biol. 2023;3(85):191–194. DOI:10.26724/2079-8334-2023-3-85-191-194.
  14. Yu B, Wang CY. Osteoporosis and periodontal diseases-An update on their association and mechanistic links. Periodontol 2000. 2022;89(1):99–113. DOI:10.1111/prd.12422.
  15. Zhu L, Zhou C, Chen S, Huang D, Jiang Y, Lan Y, et al. Osteoporosis and alveolar bone health in periodontitis niche: a predisposing factors-centered review. Cells. 2022;11(21):3380. DOI:10.3390/cells11213380.
Publication:
«World of Medicine and Biology» Vol. 22 No. 97 (2026), pp. 38-43
UDC [616-053.88+616.71-007.234]:616.31-08-039.71